In vivo 2-photon imaging of retinal biochemistry before and after retinal organoid transplantation

视网膜类器官移植前后视网膜生物化学的体内2光子成像

基本信息

  • 批准号:
    10643273
  • 负责人:
  • 金额:
    $ 19.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-06-01 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary Candidate and Career Development Plan: Dr. Browne is an assistant professor practicing vitreoretinal surgery and functioning as an engineer and physician-scientist at the University of California, Irvine. Dr. Browne established his engineering and basic biological sciences skills as a PhD student. He has balanced clinical duties with his laboratory research activities and. His long-term career goals are to engineer functional imaging tools that will advance the understanding of early and advanced eye diseases and facilitate the therapies needed to treat humans. His training thus far has been using in vitro imaging alone. To achieve his career goals, he is requesting support for training to develop functional imaging tools in vivo and the molecular tools to correctly interpret Two-photon imaging (2PI) observations from animal models. This K08 award will enable Dr. Browne to develop his scientific and professional skills in advanced imaging, fluorescence microscopy, and retinal cellular biology applied in vivo. Dr. Browne and his co-mentors, Drs. Palczewski, Seiler and Kuppermann, have developed a hands-on strategy to fulfill the training requirements through relevant course work, didactics, laboratory techniques, and collaborations at UC Irvine. The training program will prepare Dr. Browne to submit R01-level proposals to independently investigate and optimize functional retinal imaging as a tool for therapeutic discovery. Research Plan: Many blinding retinal conditions, like age-related macular degeneration, are the consequence of biochemical dysfunction and the secondary effects of inflammation and cell death. Conventional clinical tools provide valuable structural information about the retina but are unable to visualize retinal function. Non-linear optical imaging can now reveal subcellular biochemistry in vitro and has emerged as a reliable tool to study retinal disease. 2PI in mouse models demonstrates subcellular changes in energy and light cycle metabolism. Cell replacement therapy has emerged as a therapeutic candidate for advanced vision loss, and preclinical trials in rats have demonstrated visual function restoration. To understand metabolic function in retinal organoids (RtOg) before and after transplantation into blind rats, we will employ functional 2PI in vitro and in vivo as outlined in the following specific aims. 1) Investigate RtOg maturation with 2PI and correlate functional imaging data with cell-specific reporters in vitro and molecular signatures post vivo, 2) Identify functional imaging biomarkers for in vivo metabolism using 2PI of normal rats and rat with retinal degeneration, 3) Study in vivo functional 2PI of transplanted RtOgs in rats to identify alterations in functional imaging biomarkers and correlate imaging findings with visual function testing. Completion of these aims will yield time-resolved metabolic detail for specific cell populations in developing RtOgs, avail novel in vivo information about retinal biochemistry in healthy retina, diseased retina, and diseased retinas treated with retinal sheet transplantation. These discoveries will guide future translation of both functional imaging and tissue replacement therapy in humans.
Project Summary Candidate and Career Development Plan: Dr. Browne is an assistant professor practicing vitreoretinal surgery and functioning as an engineer and physician-scientist at the University of California, Irvine. Dr. Browne established his engineering and basic biological sciences skills as a PhD student. He has balanced clinical duties with his laboratory research activities and. His long-term career goals are to engineer functional imaging tools that will advance the understanding of early and advanced eye diseases and facilitate the therapies needed to treat humans. His training thus far has been using in vitro imaging alone. To achieve his career goals, he is requesting support for training to develop functional imaging tools in vivo and the molecular tools to correctly interpret Two-photon imaging (2PI) observations from animal models. This K08 award will enable Dr. Browne to develop his scientific and professional skills in advanced imaging, fluorescence microscopy, and retinal cellular biology applied in vivo. Dr. Browne and his co-mentors, Drs. Palczewski, Seiler and Kuppermann, have developed a hands-on strategy to fulfill the training requirements through relevant course work, didactics, laboratory techniques, and collaborations at UC Irvine. The training program will prepare Dr. Browne to submit R01-level proposals to independently investigate and optimize functional retinal imaging as a tool for therapeutic discovery. Research Plan: Many blinding retinal conditions, like age-related macular degeneration, are the consequence of biochemical dysfunction and the secondary effects of inflammation and cell death. Conventional clinical tools provide valuable structural information about the retina but are unable to visualize retinal function. Non-linear optical imaging can now reveal subcellular biochemistry in vitro and has emerged as a reliable tool to study retinal disease. 2PI in mouse models demonstrates subcellular changes in energy and light cycle metabolism. Cell replacement therapy has emerged as a therapeutic candidate for advanced vision loss, and preclinical trials in rats have demonstrated visual function restoration. To understand metabolic function in retinal organoids (RtOg) before and after transplantation into blind rats, we will employ functional 2PI in vitro and in vivo as outlined in the following specific aims. 1) Investigate RtOg maturation with 2PI and correlate functional imaging data with cell-specific reporters in vitro and molecular signatures post vivo, 2) Identify functional imaging biomarkers for in vivo metabolism using 2PI of normal rats and rat with retinal degeneration, 3) Study in vivo functional 2PI of transplanted RtOgs in rats to identify alterations in functional imaging biomarkers and correlate imaging findings with visual function testing. Completion of these aims will yield time-resolved metabolic detail for specific cell populations in developing RtOgs, avail novel in vivo information about retinal biochemistry in healthy retina, diseased retina, and diseased retinas treated with retinal sheet transplantation. These discoveries will guide future translation of both functional imaging and tissue replacement therapy in humans.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrew W Browne其他文献

Andrew W Browne的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
  • 批准号:
    10102692
  • 财政年份:
    2024
  • 资助金额:
    $ 19.43万
  • 项目类别:
    EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
  • 批准号:
    10639785
  • 财政年份:
    2023
  • 资助金额:
    $ 19.43万
  • 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
  • 批准号:
    23K09052
  • 财政年份:
    2023
  • 资助金额:
    $ 19.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 19.43万
  • 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
  • 批准号:
    10642988
  • 财政年份:
    2023
  • 资助金额:
    $ 19.43万
  • 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
  • 批准号:
    10635325
  • 财政年份:
    2023
  • 资助金额:
    $ 19.43万
  • 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
  • 批准号:
    10584110
  • 财政年份:
    2023
  • 资助金额:
    $ 19.43万
  • 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
  • 批准号:
    22H03243
  • 财政年份:
    2022
  • 资助金额:
    $ 19.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
  • 批准号:
    10433610
  • 财政年份:
    2022
  • 资助金额:
    $ 19.43万
  • 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
  • 批准号:
    10504138
  • 财政年份:
    2022
  • 资助金额:
    $ 19.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了